Antifungal Drugs Market Size Worth $12.7 Billion By 2025

The global antifungal drugs market size is expected to reach USD 12.7 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 1.5% during the forecast period. Increasing incidence of fungal infections worldwide is the key factor stoking the growth of the market. In addition, rise in adoption of immunosuppressive and antineoplastic agents, prosthetic devices and grafts, and broad-spectrum antibiotics has resulted in increased incidence of fungal infections in recent years.

According to statistics published by the Centers of Disease Control and Prevention in 2017, it has been estimated that every year, nearly 220,000 new individuals are affected by cryptococcal meningitis, which is a brain infection and has resulted in 181,000 deaths per year around the world. Most of the deaths were reported in sub-Saharan Africa, due to high prevalence of HIV/AIDS. This indicates the potential demand for antifungal drugs due to high prevalence of mycological infections around the globe.

As aged people are more prone to infectious diseases and chronic conditions, including HIV and cancer, rise in geriatric population worldwide is likely to stir up the demand for antifungals to treat opportunistic fungal infections. The demand for fungistatic agents is estimated to remain strong through 2025 due to mounting cases of fungal infections that are difficult to diagnose, yielding high mortality and morbidity rates.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/antifungal-drugs-market

Further key findings from the study suggest:

• Several types of fungicidal preparations, such as creams, sprays, tablets, & injections, are available. Increasing adoption of these products is anticipated to drive the market during the forecast period
• The echinocandins segment is anticipated to exhibit lucrative growth owing to their cell wall-specific fungicidal property coupled with their broad-spectrum activity against Aspergillusand Candida species without cross-resistance risks
• The candidiasis indication segment is expected to witness the fastest CAGR over the forecast period due to increasing drug resistance of the Candida species to Azoles
• North America held the largest market share in 2017. The growth of the market can be attributed to higher awareness levels pertaining to treatment of fungal infection and presence of a large target population
• Asia pacific is projected to register the fastest growth during the forecast period due to improving healthcare facilities coupled with rising government initiatives to create awareness of infectious diseases among the population
• Companies are focusing on development of effective therapeutic agents for treatment of systemic fungal infections in immune-compromised patients
• Numerous ongoing public-private partnership agreements in the pharmaceutical industry for development of novel therapeutics is poised to provide the market with lucrative growth opportunities. For instance, Astellas Pharma partnered with Vical Incorporated for the development of VL-2397, an antifungal drug for the treatment of pulmonary aspergillus.

Grand View Research has segmented the global antifungal drugs market by drug class, indication, and region:

Antifungal Drug Class Outlook (Revenue, USD Million, 2014 - 2025)

• Azoles
  • Voriconazole (Vfend)
  • Posaconazole (Noxafil)
  • Clotrimazole (Canesten)
  • Isavuconazole (CRESEMBA)
  • Others
• Echinocandins
  • Caspofungin (Cancidas)
  • Micafungin (Mycamine/ Funguard)
  • Others
• Polyenes
  • Amphotericin (AmBisome)
  • Others
• Allylamines
  • Terbinafine (Lamisil)
  • Others
• Others

Antifungal Drugs Indication Outlook (Revenue, USD Million, 2014 - 2025)

• Dermatophytosis
• Aspergillosis
• Candidiasis
  • Invasive Candidiasis
  • Vulvovaginal Candidiasis (VVC)
  • Mouth/Throat/Esophageal Candidiasis
  • Other Candida Infections
• Others

Antifungal Drugs Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Market for X-ray Photoelectron Spectroscopy to Reflect Steadfast Expansion by 2022

The global XPS market is expected to reach USD 712.4 million by 2022, according to a new report by Grand View Research, Inc. Growing application of XPS technology in different industries such as healthcare, semiconductors, aerospace, automotive, and electronics along with rising demand for research and development across all these industries is expected to drive the XPS market over the forecast period.

In addition, rising popularity of hyphenated technologies and other technological advancements such as hard X-ray photoelectron spectroscopy (HAXPES) has prompted the growth of the X-ray photoelectron spectroscopy market. The ability of XPS to accurately identify contamination in the provided sample is also expected to contribute towards boosting usage rates.

Rising demand for XPS technique for drug safety and medical research is expected to serve the market as a future growth opportunity. Presence of supportive government initiatives such as the “Safe Use Initiative” by FDA and “Drug Safety Information Survey” introduced by Health Canada for creating awareness regarding medical research and development are some notable examples likely to provide manufacturers with lucrative growth opportunities.

Access Research Report of X-ray Photoelectron Spectroscopy Market@
http://www.grandviewresearch.com/industry-analysis/xps-market

Further key findings from the report suggest:

• The global element detection market is anticipated to reach 257.05 million by 2022, at a CAGR of 6.29% from 2015 to 2022
• In terms of usage, contamination detection segment is expected to show the fastest growth during the forecast period
• In terms of application, healthcare segment is expected to dominate the market over the forecast period
• Asia pacific is expected to show the fastest growth in XPS market over the forecast period
• North America is expected to dominate the XPS market during the forecast period
• The market is partially consolidated and competitive in nature, with presence of global multinational players.
• Some of the key companies present in the market include Thermo Fisher Scientific, Kratos Analytical, Evan Analytical Group (EAG), Intertek, V G Scienta, Yokogawa, Kett and Mitsubishi Electric.                                                                                                        

Grand View Research has segmented the global XPS market on the basis of usage, application and region:

X-ray Photoelectron Spectroscopy Usage Type Outlook (Revenue, USD Million, 2012 - 2022)

• Element Detection
• Contamination Detection
• Density Estimation
• Empirical formula Determination

X-ray Photoelectron Spectroscopy Application Type Outlook (Revenue, USD Million, 2012 - 2022)

• Healthcare
• Semiconductors
• Electronics
• Aerospace
• Automotive
• Others

X-ray Photoelectron Spectroscopy Regional Outlook (Revenue, USD Million, 2012 - 2022)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Needle-Free Drug Delivery Devices Market Share, Industry Size ,Growth Analysis And Forecast To 2025

The Report Needle-Free Drug Delivery Devices Market Size, Share & Trends Analysis Report By Application, By Technology (Jet Injectors, Inhaler, Transdermal Patch, Novel Needle Free), and Segment Forecasts, 2018 – 2025

The global needle-free drug delivery device market size is poised to reach USD 16.27 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 10.5% during the forecast period. Rising usage of injections in healthcare settings such as hospitals, clinics, and ambulatory surgical centers has led to spread of infectious diseases such as Hepatitis B, Hepatitis C, and AIDS, especially in developing countries. This acts as a key driver for the needle-less drug delivery devices industry. Furthermore, rising collaborations between market players is further likely to increase competitiveness of this market. For instance, PharmaJet and Mundipharma entered into a partnership in 2018 for distributing its needle free injectors over 120 markets globally.

Moreover, technological advancements in healthcare are expected to open new avenues for market players in applications such as cancer, AIDS, and Ataxic Cerebral Palsy. For instance, polycarbonate materials are being utilized in needle free injectors owing to their advantages such as design flexibility, toughness, light weight, and process ability. The most recent example of such technology is needle-free injection insulin delivery device manufactured by QS Medical Technology Co. (QS) in September 2018.

Access Research Report of Needle-Free Drug Delivery Devices Market @ www.grandviewresearch.com/industry-analysis/needle-free-drug-delivery-devices-market

Further key findings from the report suggest:

• Novel needle-less devices accounted for a significant share of more than 25.00% in 2017 owing to their wide array of applications
• Based on applications, the vaccine delivery segment is estimated to exhibit a lucrative growth rate over the forecast period due to its increasing usage for pediatric patients
• North America held the dominant share in the global arena in 2017, due to favorable government insurance policies and increased investments in R&D by healthcare companies
• For instance, In May 2018, U.S. Congress approved “right to try” bill where patients can try unproven medical treatments and devices in case of serious illness such as orphan diseases, including NETs
• The Asia Pacific needle-free medication transportation devices industry is anticipated to witness significant growth during the same period due to rising healthcare expenditure and growing investments by many companies in the healthcare sector
• Additionally, several countries in this region are implementing laws that cater to adoption of medical devices. For instance, the Korea-U.S. Free Trade Agreement (KORUS FTA) was implemented on March 15, 2012, in which most of the medical devices in Korea were made duty free
• Some of the key companies present in the market are Antares Pharma; Injex Pharma Ag; Verdict Media Limited; Valeritas, Inc.; and 3M Company
• Industry participants are involved in extensive research activities to develop novel needless drug delivery injectors for applications such as pain management, insulin drug delivery, and vaccines delivery.

Grand View Research has segmented the global needle-free medicine delivery device market on the basis of technology, application, and region:

Needle-Free Drug Delivery Device Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Jet injectors
• Inhaler technology
• Transdermal patch technology
• Novel needle-free technologies

Needle-Free Drug Delivery Device Application Outlook (Revenue, USD Million, 2014 - 2025)

• Others Vaccine delivery
• Pain management
• Insulin delivery for diabetes
• Pediatric injections
• Others

Needle-Free Drug Delivery Device Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cell Line Development Market Share & Growth Rate by 2022

Global cell line development market size is expected to reach USD 6.24 billion by 2022, according to a new report by Grand View Research, Inc. The Increasing demand for monoclonal antibodies and patent expiration of blockbuster biologics are expected to drive the cell line development industry over the forecast period.

Increasing prevalence of autoimmune diseases and cancer are likely to increase the demand for accurate and cost effective treatment options which is expected to render a positive impact on market growth. In addition, improving healthcare infrastructure, economic development and favorable government initiatives promoting the growth of the biotechnology industry are factors contributing towards the growth of the cell line development market.

Ongoing R&D for stable & authentic cell lines and the introduction of technologically advanced processes such as single use bioreactor and micro bioreactor for large scale bioproduction are further expected to provide this market with lucrative future growth opportunities.

To request a sample copy or view summary of this report, click the link below:http://www.grandviewresearch.com/industry-analysis/cell-line-development-market

Further key findings from the study suggest:

• Reagent and media was the largest product market in 2014, owing to increasing number of cell culture procedures. Reagent and media are necessary components involved in cell line development procedures & cell culture and are cost intensive in nature. The market for reagent and media was valued at over 1.0 billion in 2014.
• Mammalian cell lines were widely used as a source for cell line development in 2014, owing to associated advantages such as accurate complex protein expression nature, critical for the production of monoclonal antibodies, vaccines, and biologics.
• Cell line development finds the largest application in the bioproduction of biologics, vaccines, Mabs, therapeutic proteins and biosimilars. Rising demand for monoclonal antibodies and vaccines are expected to boost the growth of this segment over the forecast period. The market for cell line development based bioproduction is also expected to witness lucrative growth of over 12.5% during the forecast period.
• North America was the largest market in 2014, with revenue estimated at over 800 million. The region’s market dominance is attributed to factors such as the growing adoption rates of cell culture techniques, presence of well developed healthcare infrastructure, supportive government initiatives and high healthcare expenditure levels.
• Asia Pacific cell line development market is anticipated to register rapid growth over the forecast period owing to factors such as the presence of high unmet needs, rising number of CROs (Contract Research Organization) providing pertinent services, growing R&D investments aimed at the development of stable cell lines and increasing biologics production.
• Key players in this market include European Collection of cell Cultures (ECACC), Lonza Group AG, GE Healthcare, Thermo Fisher Scientific Inc., Sartorious AG, Selexis SA, Wuxi AppTec Inc., Sigma-Aldrich Corporation, American Type Culture Collection (ATCC) and Corning Inc. 

Grand View Research has segmented the global cell line development market on the basis of product, source, type of cell line, application and region:

Global Cell Line Development Product Outlook (Revenue, USD Million, 2012 - 2022)

• Reagents and media
• Equipment Accessories and consumables
  • Incubators
  • Centrifuges
  • Bioreactors
  • Storage equipment
  • Microscopes

Global Cell Line Development Source Outlook (Revenue, USD Million, 2012 - 2022)

• Mammalian
• Non mammalian
  • Insects
  • Amphibians

Global Cell Line Development Type Of Cell Line Outlook (Revenue, USD Million, 2012 - 2022)

• Recombinant cell lines
• Hybridomas
• Continuous cell line
• Primary cell lines

Global Cell Line Development Application Outlook (Revenue, USD Million, 2012 - 2022)

• Bioproduction
• Drug discovery
• Toxicity testing
• Tissue engineering
• Research

Cell Line Development Regional Outlook (Revenue, USD Billion, 2014 - 2022)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sports Nutrition Market Latest Innovations, Drivers and Industry Key Events by 2027

The global sports nutrition market size is expected to reach USD 31.0 billion by 2027, registering a CAGR of 8.9% over the forecast period, according to a new report by Grand View Research, Inc. Increasing importance of an active lifestyle owing to rise in sedentary jobs and shift in demographic base from core athletes to recreational athletes and lifestyle users are the key factors expected to drive the market. Moreover, increasing number of health and fitness centers and gyms, rising consumer awareness regarding the adoption of a healthy lifestyle, and demand for these products from athletes is expected to boost the market growth.

Widespread product availability due to the presence of large companies is expected to drive the demand for these products. For instance, in 2018, Amazon launched its private label sports supplement brand “OWN PWR” for U.S. consumers. Companies such as Glanbia Plc; Abbott Laboratories Inc.; Neutra Science Labs; Hormel Foods Corporation; and GNC Corporation are the key players operating in the market. Moreover, favorable government initiatives to promote health, growing base of health-conscious population, and rising awareness about sedentary health risks further drive the market.

Moreover, the U.S. population is becoming increasingly health-conscious and hence focuses on adopting an active lifestyle. The International Health, Racquet & Sportsclub Association (IHRSA), a Boston-based, commercial health clubs trade association, reported a 3.6% rise in the number of health club members, from 55.3 million in 2015 to 57.3 million in 2016. The number of health clubs in U.S. increased by 5.2%, from 36,540 in 2016 to 38,447 in 2017. These health clubs and fitness centers have consulting dietitians, which influences the consumption of sports nutrition products among trainers and fitness enthusiasts.

Access Research Report of Sports Nutrition Market @
https://www.grandviewresearch.com/industry-analysis/sports-nutrition-market

Further key findings from the report suggest:

• Sports supplements emerged as the largest product segment in 2019 with a share of over 80.0% of the global sports nutrition market owing to increasing commercialization of these supplements and wide product range including creatine and whey protein supplements
• On the basis of distribution channel, bricks and mortar dominated the market in 2019 owing to high consumer base for retail stores  
• Ecommerce is projected to be the fastest-growing segment over the forecast period owing to increasing popularity of ecommerce platforms and the associated benefits such as discounts and convenience
• North America dominated the global market in 2019 due to growing awareness about nutritional supplements and rise in government initiatives promoting sports-related activities
• Key players operating in the market include Glanbia plc; Hormel Foods Corporation; General Nutrition Centers, Inc.;Abbott; The Coca-Cola Company; and Clif Bar & Company.

Grand View Research has segmented the global sports nutrition market on the basis of product, distribution channel, and region:

Sports Nutrition Product Outlook (Revenue, USD Million, 2016 - 2027)

• Sports Drinks
• Sports Supplements
• Sports Foods

Sports Nutrition Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)

• Ecommerce
• Bricks and mortar

Sports Nutrition Regional Outlook (Revenue, USD Million, 2016 - 2027)

• NorthAmerica
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Microelectronic Medical Implants Market is Projected to Boost $57.12 Billion by 2025| Key Industry Participants Zoll Medical; Boston Scientific Corporation

The global microelectronic medical implants market size is anticipated to reach USD 57.12 billion by 2025, according to a new report by Grand View Research, Inc., registering a 9.8% CAGR during the forecast period. Increasing prevalence of cardiac disorders, epilepsy, and Parkinson’s disease, growing regulatory approvals for new devices and equipment, rising geriatric population, and introduction of new products are key factors driving market growth.

Regulatory authorities such as U.S. FDA have approved several new products and devices to be used by end users, most of which are equipped with new and innovative technologies that cater to varied consumer demands. These technologies also increase the ease of use of these products. For instance, in July 2017, Cochlear Ltd. introduced to the market a cochlear implant sound processor for iPhone. The U.S. FDA approved this innovation in June 2017.

Increasing prevalence of diseases such as epilepsy, cardiac disorders, and Parkinson’s disease have upped the sales of microelectronic electronic implants such as defibrillators, pacemakers, and neurostimulators. As per WHO, approximately 50 million people have epilepsy, globally, making it one of the most common neurological disorders. The condition can be treated using neurostimulators that prevent seizures.

Access Research Report of Microelectronic Medical Implants Market@
https://www.grandviewresearch.com/industry-analysis/microelectronic-medical-implants-market

Further key findings from the study suggest:

• By product, the pacemakers and defibrillators segment accounted for the largest share in 2016 owing to increasing prevalence of cardiovascular diseases and rising geriatric population
• RF technology accounted for the largest share in 2016 as it is employed in wireless implants and helps researchers and clinicians monitor patient health, capture physiological data, and study normal and abnormal functioning of the body
• North America commanded the largest share in the microelectronic medical implants market in 2016 and is expected to maintain its position over the forecast period. This is owing to favorable government policies, increasing FDA approvals for various medical devices in U.S., and high incidence of cardiac diseases
• Key market players include Zimmer Biomet Holdings, Inc.; Cochlear Ltd.; Medtronic plc; Abbott Laboratories; Zoll Medical; Boston Scientific Corporation; LivaNova PLC; Biotronik; Schiller; and Koninklijke Philips N.V.

Grand View Research has segmented the global microelectronic medical implants market on the basis of product, technology, and region: 

Microelectronic Medical Implants Product Outlook (Revenue, USD Million, 2014 - 2025)

• Pacemakers & Defibrillators
• Neurostimulators
• Implantable Drug Pumps
• Spinal Fusion Stimulators
• Cochlear Implants
• Ocular Implants
• Others

Microelectronic Medical Implants Technology Outlook (Revenue, USD Million, 2014 - 2025)

• RF Technology
• Sensors
• Other Technology

Microelectronic Medical Implants Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Genomics Market Will Increase at a CAGR of 7.7% During 2020 to 2027

The global genomics market size is expected to reach USD 31.1 billion by 2027, registering a CAGR of 7.7% over the forecast period, according to a new report by Grand View Research, Inc. Significant changes in disease management processes along with advancements in genomics and personalized medicine are expected to propel the market. 

Increasing pool of market innovators such as 23andMe,Oxford Nanopore Technologies, and Veritas Genetics that have launched breakthrough genomic technologies in recent years are also contributing toward market development. 23andMe has expertise in developing direct-to-consumer genomic tests targeted toward disease prognosis and has recently received FDA approval for its commercialization.

MinION - a trademark sequencing device of Oxford Nanopore Technologies, is witnessing significant traction owing to its ability to sequence any fragment length of DNA in real time. On the other hand, Veritas Genetics offers an affordable solution for a complete readout of the genomic sequence. Earlier procured only by doctors, these tests can now be taken by anyone curious about their DNA and costs approximately USD 1,000. The company has also begun the commercialization of this technique for newborn’s genomic sequencing applications in China in 2017.

Access Research Report of Genomics Market@
https://www.grandviewresearch.com/industry-analysis/genomics-market

Further key findings from the report suggest:

• The consumables and reagents deliverable segment is expected to register highest growth rate owing to high costs associated with specific essential reagents along with high volume requirement
• The computational services deliverable segment is set to expand at a considerable CAGR from 2020 - 2027 owing to the increasing demand for computational sequence alignment and analysis among molecular biologists
• Development of predictive biomarkers targeted toward diagnosis and monitoring and substantial investments by biotechnology and pharmaceutical companies have contributed significantly to the revenue generated by the biomarker discovery application segment in 2019
• Asia Pacific is a potentially lucrative market for genomics and is anticipated to expand at the highest CAGR of 9.1%
• Key players of genomics market include 23andMe; F. Hoffmann-La Roche Ltd.; BGI; Myriad Genetics Inc.; Danaher.; Pacific Biosciences; Illumina; Agilent Technologies; Thermo Fisher Scientific, Inc.; Foundation Medicine; Oxford Nanopore Technologies; and Bio-Rad Laboratories.

Grand View Research has segmented the global genomics market on the basis of deliverables, application and technology, end use, and region:

Genomics Deliverable Outlook (Revenue, USD Million, 2016 - 2027)

• Products
  • Instruments & Software
  • Consumables & Reagents
• Services
  • Core Genomics Services
  • NGS-based Services
  • Biomarker Translation Services
  • Computational Services
  • Others

Genomics Application & Technology Outlook (Revenue, USD Million, 2016 - 2027)

• Functional Genomics
  • Transfection
  • Real-time PCR
  • RNA interference
  • Mutational analysis
  • SNP analysis
  • Microarray analysis
• Epigenetics
  • Bisulfite sequencing
  • Chromatin immunoprecipitation-sequencing (ChIP & ChIP-Seq)
  • Methylated DNA immunoprecipitation (MeDIP)
  • High resolution melt (HRM)
  • Chromatin accessibility assays
  • Microarray analysis
• Pathway Analysis
  • Bead-based analysis
  • Microarray analysis
  • Real-time PCR
  • Proteomics tools (2-D PAGE; yeast 2-hybrid studies)
• Biomarker Discovery
  • Mass spectrometry
  • Real-time PCR
  • Microarray analysis
  • Statistical analysis
  • Bioinformatics
  • DNA sequencing
• Others

Genomics End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Clinical & Research Laboratories
• Academic & Government Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other End Users

Genomics Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• Middle East and Africa (MEA)
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Computational Biology Market Growth with Worldwide Industry Analysis by 2026

The global computational biology market size is expected to reach USD 13.6 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 21.3% during the forecast period. Rise in clinical studies in pharmacokinetics and pharmacogenomics for novel drug delivery and increase in the application of computational biology for bioinformatics R&D programs for the population based sequencing studies are fueling the market growth.

Rising use of computational tools in genomics, epi-genomics, proteomics, and meta-genomics to understand 3D protein structural analysis, protein-protein interactions, and gene sequencing and expression studies coupled with increasing research activities in drug designing and disease modeling is expected to drive the growth. However, lack of skilled resources to operate computational tools is expected to restrain the growth of the computational biology market during the forecast period.

Many pharmaceutical companies are seeking funding from angel investors. For instance, in February 2019, StemoniX Inc., the U.S. based provider of product and services for drug discovery and development, received funding of USD 14.40 million from a group of investors. Brightstone Venture Capital was the major financer and was later joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus received funding of USD 5.0 million to speed up the discovery of new drugs. With this finding, the research institute is planning to procure and install drug discovery research instruments and other drug discovery platforms.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/computational-biology-market

Further key findings from the report suggest:

• Cellular and biological simulation is expected to expand at the fastest CAGR of over 15.0% over the forecast period. The shift in sequencing studies towards further analysis of the nature of various biological proteins as a part of the development of personalized medicine, is projected drive the growth
• Drug discovery and disease modelling applications led the market, accounting for 38.0% of the global market in terms of revenue in 2018. The factors responsible for this growth are extensive drug pipelines for the global drug manufacturing firms
• North America was the largest regional market, accounted for more than 45.0% of the global revenue in 2018. Increase in research activities for drug discovery processes and innovations in biological computation tools are anticipated to drive the growth
• Asia Pacific is anticipated to witness the fastest of around CAGR of 23.0% during the forecast period, due to increasing expenditure in the clinical studies for the pharmaco-kinetics and pharmaco-genomics
• Some of the players operating in the computational biology market include Chemical Computing Group Inc.; Compugen Ltd.; Simulation Plus Inc.; Genedata AG; Certara; Insilico Biotechnology AG; Accelrys; Rhenovia Pharma SAS; Entelos; Nimbus Discovery LLC; and Rhenovia Pharma SAS.

Grand View Research has segmented the global computational biology market based on application, service, end use, and region:

Computational Biology Application Outlook (Revenue, USD Million 2015 - 2026)

• Cellular & Biological Simulation
  • Computational Genomics
    • Databases
    • Infrastructure/Hardware
    • Software & Services
  • Computational Proteomics
  • Pharmacogenomics
  • Others (Transcriptomics/Metabolomics)
• Drug Discovery & Disease Modelling
  • Target Identification
  • Target Validation
  • Lead Discovery
  • Lead Optimization
• Preclinical Drug Development
  • Pharmacokinetics
  • Pharmacodynamics
• Clinical Trials
  • Phase I
  • Phase II
  • Phase III
• Human Body Simulation Software

Computational Biology Services Outlook (Revenue, USD Million 2015 - 2026)

• In-house
• Contract

Computational Biology End-use Outlook (Revenue, USD Million 2015 - 2026)

• Academics
• Industry
• Commercial

Computational Biology Regional Outlook (Revenue, USD Million 2015 - 2026)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Guidewires Market Size to Expand at 6.3% CAGR from 2019 - 2025

The global guidewires market size is expected to reach USD 2.90 billion by 2025, at a CAGR 6.3% over a forecast period, according to a new report by Grand View Research, Inc. High prevalence of target diseases such as ischemic heart disease, brain aneurysm, and nephrolithiasis coupled with rise in preference for minimally invasive surgical procedures is anticipated to drive the growth. Increase in application of guidewires in neurovascular interventions is also among key factors driving the market.

Coronary heart disease is a major cause of disabilities and mortality globally. As per the Heart Disease and Stroke Statistics 2018, overall prevalence of myocardial infarction is nearly 7.9 million in U.S., which is 3% of the U.S. adult population, as of 2017. This study also states that the medical cost of coronary heart disease in projected to increase by 100% between 2013 and 2030. Moreover, as per OECD report, HEALTH AT A GLANCE 2015, the use of angioplasty has increased among the OECD countries, in the past 20 years. This is driving the demand for guidewires.

Technological advancements in terms of accessibility, improved flexibility with minimal deformity, and excellent tip shape retention is expected to drive the market. Motion Hybrid Wire Guide is an example of the technological advancement in guidewires. In January 2017, Cook Medical announced the launch of a two in one guidewire, Motion Hybrid Wire Guide. This product exhibits the features of Teflon fixed core guidewire and nitinol access guidewire into a single device.

To request a sample copy or view summary of this report, click the link below:https://www.grandviewresearch.com/industry-analysis/guidewires-market

Further key findings from the report suggest:

• In 2018, coronary guidewires held the largest revenue share owing to high demand in cardiovascular interventions
• Neurovascular guidewires segment is expected to expand at a rapid CAGR of 10.2% over the forecast period owing to the technological advancements and rising incidences of neurovascular disorders
• In 2018, coated guidewires segment held the leading market share of 90.6% owing to high preference for coated guidewires in minimally invasive surgeries
• North America held the largest revenue share of 33.7% owing to high adoption of technologically advanced devices leading to improved treatment rates and rise in preference of minimally invasive surgeries
• Asia pacific is expected to witness the fastest CAGR of 8.4% over the forecast period owing to growing geriatric population and burden of chronic diseases coupled with improving treatment rates
• Key players operating in the guidewires market include Boston Scientific Corporation, Abbott, Cordis (Cardinal Health) Angiodynamics, Medtronic, Stryker, Cook, Codman Neuro, and Terumo Medical Corporation.

Grand View Research has segmented the global guidewires market on the basis of product, coatings, raw material, and region:

Guidewires Product Outlook (Volume, Thousand Units; Revenue, USD Million, 2014 - 2025)

• Coronary
• Peripheral
• Urology
• Neurovascular

Guidewires Coating Outlook (Volume, Thousand Units; Revenue, USD Million, 2014 - 2025)

• Coated
  • Hydrophilic
  • Hydrophobic
• Non coated

Guidewires Raw Materials Outlook (Volume, Thousand Units; Revenue, USD Million, 2014 - 2025)

• Nitinol
• Stainless Steel
• Others

Guidewires Regional Outlook (Volume, Thousand Units; Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Tissue Diagnostics Market to Witness Soaring Growth During 2020 – 2027

The global tissue diagnostics market size is anticipated to reach USD 6.6 billion by 2027, growing at a CAGR of 5.9% during the forecast period, according to a new report by Grand View Research, Inc. Accelerating demand for automated tissue diagnostic systems due to the lack of skilled pathologists has driven the market. The advent of advanced imaging techniques, such as autofluorescence, that minimize the need for invasive diagnostics further supplement market growth.

The digitalization of tissue diagnostic techniques has resulted in the improvement of workflows and better patient care. Ongoing strategic models taken-up by key companies to enhance the efficiency of diagnostics also drives the market. For instance, in December 2019, Philips collaborated with Paige to provide clinical-grade artificial intelligence-based solutions to pathology laboratories. This enhanced the speed and accuracy of cancer diagnostics in laboratories.

Tissue diagnostic techniques, such as immunohistochemistry (IHC) or in situ hybridization, are used in companion diagnostics (CDx) to determine the quantity of a target analyte present in the sample. Introduction of CDx tests, such as the launch of the VENTANA HER2 Dual ISH CDx

To request a sample copy or view summary of this report, click the link below:https://www.grandviewresearch.com/industry-analysis/tissue-diagnostics-market

Further key findings from the report suggest:

• IHC tests are highly adopted as these tests are specific and helpful in identifying the variations between different types of cancer, resulting in the largest revenue share
• A rise in the investments for the development of advanced infrastructure to digitalize images is anticipated to drive the digital pathology segment with the fastest CAGR.
• Moreover, an increase in the demand for automated modalities owing to a dearth of skilled pathologists further compliments this growth
• A large number of breast cancer cases coupled with a rise in the application of digital image processing techniques on histopathological samples for breast cancer detection contributes to the largest share of breast cancer
• Prostate cancer is anticipated to register lucrative growth owing to the extensive ongoing research pertaining to early diagnosis and prevention of this disease
• Hospitals dominated the market in terms of revenue share due to the high adoption of tissue diagnostics solutions. These solutions provide accurate results in minimal time than conventional testing procedures
• North America accounted for the largest revenue share owing to increasing collaborations between pharmaceutical and biotech firms to expand their product offerings
• The requirement of better laboratory management systems, growing demand for novel patient care facilities, and favorable regulatory framework, boost the Asia Pacific market at a lucrative pace
• Abbott, QIAGEN, Roche, Siemens, Danaher, Thermo Fisher, and Merck are some key participants operating in the tissue diagnostics market
• Key vendors are engaged in novel product developments, partnership, and acquisition models to maintain their revenue share in the market.

Grand View Research has segmented the global tissue diagnostics market on the basis of technology and product, application, end use, and region:

Tissue Diagnostics Technology & Product Outlook (Revenue, USD Million, 2016 - 2027)

• Immunohistochemistry
  • Instruments
  • Slide Staining Systems
  • Tissue Microarrays
  • Tissue Processing Systems
  • Slide Scanners
  • Other products
  • Consumables
  • Antibodies
  • Reagents
  • Kits
• In Situ Hybridization
  • Instruments
  • Consumables
  • Software
• Primary & Special Staining
• Digital Pathology and Workflow
  • Whole Slide Imaging
  • Image Analysis Informatics
  • Information Management System Storage & Communication
• Anatomic Pathology
  • Instruments
  • Microtomes & Cryostat microtomes
  • Tissue processors
  • Automatic strainers
  • Other products
  • Consumables
  • Reagents & Antibodies
  • Probes & Kits
  • Others

Tissue Diagnostics Application Outlook (Revenue, USD Million, 2016 - 2027)

• Breast Cancer
• Non-small Cell Lung Cancer
• Prostate Cancer
• Gastric Cancer
• Other Cancers

Tissue Diagnostics End-Use Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals
• Research Laboratories
• Pharmaceutical Organizations
• Contract Research Organizations (CROs)

Tissue Diagnostics Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Radiofrequency Ablation Devices Market Advanced Technologies and Growth Opportunities Worldwide By 2026

The Report Radiofrequency Ablation Devices Market Size, Share & Trends Analysis Report By Product (Disposable, Capital, Reusable Equipment), By Application, By Region, And Segment Forecasts, 2019 - 2026

The global radiofrequency ablation devices market size is anticipated to reach USD 6.7 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to register a CAGR of 11.6% during the forecast period. Increasing preference for minimally invasive surgeries, growing geriatric population, and rise in healthcare spending for better disease treatment are expected to propel the growth.

According to the American Society of Plastic Surgeons, by the end of 2015, 15.9 million minimally invasive cosmetic surgeries were performed in U.S. According to the Centers for Disease Control and Prevention (CDC), more than six million laparoscopic procedures are performed across the U.S. and EU countries every year.

Radiofrequency ablation is now used early in the management of patients suffering from atrial tachycardia or atrial fibrillation or other kinds of coronary disease. This factor is anticipated to boost the market growth. According to the American College of Cardiology Foundation, coronary heart disease is the leading cause of deaths (43.8%) in U.S., followed by stroke (16.8%), heart failure (9.0%), high BP (9.4%), and other CVDs (17.9%). By 2035, the total cost of CVD is expected to reach USD 1.1 trillion and is projected to affect 45.1% (130 million) adults in U.S.

Radiofrequency ablation can also be used to reduce neck pain, low-back pain, arthritis, and pelvic and peripheral nerve pain. According to WebMD LLC., RFA has been proven to be effective in more than 70% of the patients experiencing pain. Pain relief from RFA can last from six to 12 months or even a year.

Access Research Report of Radiofrequency Ablation Devices Market @ https://www.grandviewresearch.com/industry-analysis/radiofrequency-ablation-devices-market

Further key findings from the report suggest:

• Disposable equipment held the largest market share in 2018 due to reduced morbidity and mortality and the ability of the equipment to provide treatment in an outpatient setting. For example, Radiopaque RF cannula (Halyard Worldwide, Inc) provides improved visualization under fluoroscopy for accurate positioning, resulting in a targeted treatment
• Cardiology and cardiac rhythm management is anticipated to be the fastest-growing segment during the forecast period due to disease prevalence, growing awareness, and adoption of minimally invasive operations. In 2012 RFA-Academia launched an initiative to increase awareness in Europe and to teach endoscopists safe and justified application of RFA to reduce the disease burden
• North America is anticipated to continue leading the radiofrequency ablation devices market during the forecast period due to high healthcare expenditure, incidence of cardiac disease and cancer, and the number of patients suffering from pain
• Asia Pacific is expected to witness significant growth over the next decade due to increasing demand for minimally invasive procedures to treat cancer and growing awareness regarding the benefits of ablation method over the conventional surgical procedures
• Some of the key players are Boston Scientific Corporation; Medtronic; Stryker; Cosman Medical, Inc.; St. Jude Medical; Smith & Nephew; Johnson & Johnson (J&J) Services, LLC; and AngioDynamics.

Grand View Research has segmented the global radiofrequency ablation devices market based on type and region:

Radiofrequency Ablation Devices Product Outlook (Revenue, USD Million, 2015 - 2026)

• Disposable Equipment
• Capital Equipment
• Reusable Equipment

Radiofrequency Ablation Devices Mode of Delivery Outlook (Revenue, USD Million, 2015 - 2026)

• Surgical Oncology
• Cardiology & Cardiac Rhythm Management
• Cosmetology
• Gynecology
• Pain Management

Radiofrequency Ablation Devices Regional Outlook (Revenue, USD Million, 2015 - 2026)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

ROADM WSS Component Market To Make Great Impact In Near Future by 2025

The Report ROADM WSS Component Market Size, Share & Trends Analysis Report By End Use, By Type (Blocker-based, Edge ROADMs, PLC-based, WSS), By Node, By Application, And Segment Forecasts, 2018 - 2025

The global ROADM WSS component market size is expected to reach USD 1.32 billion by 2025, according to a new study conducted by Grand View Research, Inc., progressing at a CAGR of 12.1% during the forecast period. Soaring need for components that provide flexibility to easily manage wavelengths and monitor network operations are expected to stimulate the growth of the market.

Communication service providers continue to face challenges to modify existing optical networks to meet increasing demand. Traditionally, they modify network required for addition of new wavelengths or change distribution of current wavelengths. ROADM WSS components help overcome these challenges by allowing communication service providers to add new wavelengths without disturbing the current optical networks.

In addition, ROADM WSS components offer various benefits such as remote process management, reduced network operation cost, and full monitoring and control over high-capacity network infrastructure. These factors are also estimated to accelerate ROADM WSS component market growth.

Increasing adoption of dynamic ROADMs coupled with a surging demand for Wavelength Selective Switches (WSS) enabled ROADMs is anticipated to bolster the growth of the market. Furthermore, rising video traffic coupled with spiraling demand for Internet Protocol television (IPTV) is projected to fuel growth prospects.

Key market players are focusing on developing ROADM-based optical transport incorporated with electrical switching, which is flexible, compact, and can address requirements such as high wavelength speed, improved spectral efficiency, and minimized power consumption. Growing demand for increased bandwidth encourages network operators to deploy ROADM-based optical transport incorporated with electrical switching. This is further projected to keep market growth prospects upbeat.

Access Research Report of ROADM WSS Component Market @ https://www.grandviewresearch.com/industry-analysis/the-global-roadm-wss-component-market

Further key findings from the report suggest:

• The Wavelength Selective Switches (WSS) segment is poised to register the highest CAGR of 12.9% during the forecast period, owing to rising demand for fast network speeds and growing network data traffic
• The multi-node segment is likely to experience significant growth during the same period. Metro networks are shifting from centralized data centers to distributed data centers to increase user data access speed and to improve user experience, which in turn is expected to supplement the growth of the segment
• The long haul application segment is estimated to post a CAGR of over 12.8% during the forecast period. This growth of the segment can be attributed to development of energy efficient ROADM architecture for long haul applications
• The communication segment is anticipated to dominate market throughout the forecast horizon owing to increasing adoption of ROADM WSS components by telecom service providers that assist in minimizing operational costs and offers enhanced communication services
• North America is projected to lead the market until 2025 and is poised to reach USD 350.6 million owing to burgeoning adoption of ROADM WSS components to offer seamless communication services to users
• Prominent industry participants include AC Photonics, Inc.; Active Optical MEMS, Inc.; Aegis Lightwave, Inc.; Agiltron, Inc.; Cisco Systems, Inc.; Corning Incorporated; DuPont Photonics Technologies, LLC ; Finisar Corporation; Fujitsu Limited; ADVA Optical Networking; Sinclair Manufacturing Company; and Xerox Corporation.

Grand View Research has segmented the global ROADM WSS component market on the basis of type, node, application, end use, and region:

ROADM WSS Component Type Outlook (Revenue, USD Million, 2014 - 2025)

• Blocker-based
• Edge ROADMs
• PLC-based
• Wavelength Selective Switches (WSS)

ROADM WSS Component Node Outlook (Revenue, USD Million, 2014 - 2025)

• Two-node
• Multi-node

ROADM WSS Component Application Outlook (Revenue, USD Million, 2014 - 2025)

• Long Haul
• Metro

ROADM WSS Component End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Communication
• Others

ROADM WSS Component Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wealth Management Software Market to Expand At A CAGR Of 15.3% from 2019 to 2025

The Report Wealth Management Software Market Size, Share & Trends Analysis Report By Advisory Mode (Human, Robo), By Deployment (Cloud, On-premise), By Enterprise Size, By End Use, By Application, And Segment Forecasts, 2019 - 2025

The global wealth management software market size is expected to reach USD 5.80 billion by 2025, registering a CAGR of 15.3% from 2019 to 2025, according to a new study conducted by Grand View Research, Inc. Growing need for digital tools that can automate the wealth management process is expected to drive the global market over the forecast period. Banks, trading houses, brokerage firms, forex traders, and asset management firms are some of the major end users of wealth management software. Apart from being cost-effective, these platforms can benefit end users by helping in wealth management and workflow automation. These platforms can also enhance digital engagement by providing omnichannel access and an open architecture, which can integrate seamlessly across various wealth management applications.

Such benefits bode well for the market growth. Wealth management software can also serve as advisory tools that ensure compliance with local and international regulatory requirements, help in tracking the market, and capture the investment opportunities for the users. Such capabilities are expected to drive their demand further. A wealth management software can typically provide the infrastructure necessary to support all the processes and operations asset managers have to undertake. Moreover, advances in technology are allowing financial advisors to introduce chatbots, intuitive client portals, biometrics, and enhanced mobile apps as part of the efforts to improve the customer experience as well as to attract new clients.

Access Research Report of Wealth Management Software Market @ https://www.grandviewresearch.com/industry-analysis/wealth-management-software-market

Further key findings from the study suggest:

• Robo advisory mode is anticipated to record the highest CAGR of 16.0% from 2019 to 2025 as it is cost-effective and can potentially help investors by providing information on assets in real time
• The cloud segment is expected to emerge as the largest segment over the forecast period as cloud-based deployment helps in minimizing the operational costs and ensures easy access to the data
• The financial advice and management segment is anticipated to expand at the highest CAGR of 16.0% from 2019 to 2025 due to growing demand for tools to manage finances
• The trading and exchange firms segment is anticipated to reach USD 1.01 billion by 2025 as individuals are increasingly investing in equity and forex to augment their financial gains
• North America is expected to be the dominant market over the forecast period and is anticipated to reach USD 2.09 billion by 2025 as advisory firms in the region are increasingly adopting wealth management software
• Some of the key industry participants include Fiserv, Inc.; Temenos Headquarters SA; Fidelity National Information Services, Inc.; Profile Software; SS&C Technologies Holdings, Inc.; SEI Investments Company; Finantix, Comarch SA; Objectway S.p.A.; and Dorsum Ltd.

Grand View Research has segmented the global wealth management software market on the basis of advisory mode, deployment, application, end use, and region:

Wealth Management Software Advisory Mode Outlook (Revenue, USD Billion, 2014 - 2025)

• Human Advisory
• Robo Advisory
• Hybrid

Wealth Management Software Deployment Outlook (Revenue, USD Billion, 2014 - 2025)

• Cloud
• On-premise

Wealth Management Software Application Outlook (Revenue, USD Billion, 2014 - 2025)

• Financial Advice & Management
• Portfolio, Accounting, & Trading Management
• Performance Management
• Risk & Compliance Management
• Reporting
• Others

Wealth Management Software Enterprise Size Outlook (Revenue, USD Billion, 2014 - 2025)

• Large Enterprises
• Small & Medium Enterprises (SMEs)

Wealth Management Software End Use Outlook (Revenue, USD Billion, 2014 - 2025)

• Banks
• Investment Management Firms
• Trading & Exchange Firms
• Brokerage Firms
• Others

Wealth Management Software Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wearable Sensors Market to Witness Soaring Growth During 2018 - 2025

The global wearable sensors market size is anticipated to reach USD 2.86 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a phenomenal CAGR of 38.8% during the forecast period. Wearable sensors are a vital aspect of wearable devices owing to growing focus on health and fitness monitoring activities. Wearable sensors are emerging as a revolution in monitoring healthcare and fitness parameters and reducing overall hospital cost for patients.

Wearable sensors are expected to gain traction over the forecast period. The application of these sensors in fitness bands is estimated to hold largest market share in 2016. However, the smart watch segment is anticipated to exhibit the highest CAGR during the forecast period. The growth of the segment is accredited to its capabilities in monitoring and rendering a comprehensive analysis of user activities. As technology advances, end users such as Apple, Samsung, and Fossil are focusing on providing game-changing products, which is a key determinant driving the popularity of wearable sensors.

The consumer segment is expected to remain dominant with fitness tracking emerging as a key trend among users in the recent past. Increase in demand for wearable sensors for remote monitoring of health and fitness through motion sensing technologies and data analysis techniques is anticipated to be a major factor driving segment growth. The healthcare vertical is anticipated to grow at a healthy CAGR over the forecast period, fueled by technological developments in remote monitoring.

To request a sample copy or view summary of this report:https://www.grandviewresearch.com/industry-analysis/global-wearable-sensor-market

Further key findings from the report suggest:

• The global wearable sensors market accounted for USD 149.3 million in 2016 and is expected to grow at a CAGR of 38.8% from 2017 to 2025
• The smart watch segment is anticipated to reach USD 1,083.3 million by 2025 and is expected grow at a high rate over the forecast period
• The fitness band segment dominated the market in 2016, with an estimated USD 48.5 million
• The consumer vertical emerged as the largest segment and is estimated to generate revenue over USD 1,253.5 million by 2025
• Demand for wearable sensors in defense is anticipated to witness moderate growth over the forecast period
• Asia Pacific is expected to be the fastest-growing region over the forecast period. Numerous enterprises and several new players within China and Japan have been investing in advanced sensor manufacturing. The regional market is expected to exhibit a CAGR of 41.0% over the forecast period
• Key players in the wearable sensors market include Robert Bosh GmbH, STMicroelectronics N.V., NXP Semiconductors N.V., Texas Instruments, and Knowles Electronics, LLC.

Grand View Research has segmented the global wearable sensors market on the basis of sensor type, device, vertical, and region:

Wearable Sensor Type Outlook (Revenue, USD Million, 2014 - 2025)

• Accelerometer
• Gyroscope
• Optical
• Force & pressure
• Inertial sensor
• Temperature
• Magnetometers
• Medical based sensors
• Others

Wearable Sensors Device Outlook (Revenue, USD Million, 2014 - 2025)

• Smart Watch
• Fitness band
• Smart glasses
• Smart fabric
• Smart footwear
• Other wearable

Wearable Sensors Vertical Outlook (Revenue, USD Million, 2014 - 2025)

• Consumer
• Defense
• Healthcare
• Industrial
• Others

Wearable Sensors Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Video Analytics Market Revenue is Expected to Reach $9.4 Billion by 2025

The global video analytics market size is expected to reach USD 9.4 billion by 2025, according to a new study by Grand View Research, Inc., registering a 22.8% CAGR over the forecast period. Increasing demand for intelligent security surveillance systems, which can be used for estimating key trends and deriving patterns, is the key factor driving market growth. In addition, increasing concerns over public safety and use of video analytics in criminal investigations are positively impacting demand for video analytics solutions.

Apart from surveillance, video analytics solutions have also found increasing application in the retail sector for estimating average footfall, gender bifurcation, display effectiveness, and attractiveness of shelf space. Furthermore, superstores and mega marts have started implementing these systems to gain insight into consumer behavior.

Use of advanced algorithm technology in video analytics enables examination of captured videos frame by frame, irrespective of light exposure, thereby making video analytics a reliable and efficient choice for ensuring security. Furthermore, industries such as transportation, retail, and healthcare are witnessing significant increase in the adoption of video analytics, owing to rising application of intrusion detection, license plate recognition, crowd management, and congestion detection in these industries.

Access Research Report of Video Analytics Market

Further key findings from the study suggest:

• Facial recognition is expected to emerge as the fastest growing application segment with a CAGR of 25.9% from 2017 to 2025. This can be attributed to widening scope of facial recognition solutions for surveillance purposes at malls, events, airports, and public transport, among others
• By type, the services segment is projected to register the highest CAGR of 24.0% for the next eight years. This can be attributed to increasing demand for and installation of video analytics solutions, which are, in turn, propelling demand for related managed and professional services
• The cloud segment is anticipated to emerge as the most preferred deployment option for video analytics solutions as it offers flexibility and convenience, allows remote access, and provides easy maintenance
• North America accounted for the largest share in 2016 and is driven by presence of prominent market players who consistently work on developing new and innovative technologies in video analytics
• The retail end-use segment is anticipated to register the highest CAGR of 25.6% over the forecast period.  This may be attributed to use of video analytics in applications such as people counting, display and promotion effectiveness, product placement and store layout, and customer preference pattern analysis
• Asia Pacific is expected to experience the highest growth from 2017 to 2025, driven by emerging economies such as India and China. These nations are expected to augment their expenditure on intelligent and security surveillance systems
• Key industry participants include Cisco Systems, Inc.; Axis Communications AB; Bosch Security Systems GmbH; Agent Video Intelligence Ltd.; Honeywell International Inc.; IBM Corporation; AllGoVision Technologies Pvt. Ltd.; Genetec Inc.; Aventura Inc.; and i2v System Pvt. Ltd.

Grand View Research has segmented the global video analytics market based on type, deployment, application, end use, and region.

Video Analytics Type Outlook (Revenue, USD Million, 2014 - 2025)

• Software
• Services

Video Analytics Deployment Outlook (Revenue, USD Million, 2014 - 2025)

• Cloud
• On-premise

Video Analytics Application Outlook (Revenue, USD Million, 2014 - 2025)

• Crowd Management
• Facial Recognition
• Intrusion Detection
• License Plate Recognition
• Motion Detection
• Others

Video Analytics End-use Outlook (Revenue, USD Million, 2014 - 2025)

• BFSI
• City
• Critical Infrastructure
• Education
• Government
• Retail
• Transportation
• Others

Video Analytics Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East & Africa (MEA)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.